Table 1 Clinicopathological characteristics of all patients
Variable | Number | Percentage (%) |
|---|---|---|
Gender | ||
Male vs. female | 174/85 | 67.2/32.8 |
Age (year) | 55 | |
HBV infection | ||
Positive vs. negative | 137/122 | 52.9/47.1 |
HBV-DNA load (IU/mL) | ||
≥ 103 vs. < 103 | 59/200 | 22.8/77.2 |
ALT (U/L) | ||
≤ 50 vs. > 50 | 220/39 | 84.9/15.1 |
AST (U/L) | ||
≤ 40 vs. > 40 | 203/56 | 78.4/21.6 |
γ-GT (U/L) | ||
≤ 50 vs. > 50 | 126/133 | 48.0/52.0 |
TBIL (μmol/L) | ||
≤ 17 .1 vs. > 17.1 | 167/92 | 64.5/35.5 |
ALP (U/L) | ||
≤ 150 vs. > 150 | 178/81 | 68.7/31.3 |
Cirrhosis | ||
Yes vs. no | 82/217 | 31.7/68.3 |
Child-Pugh class | ||
A vs. B | 247/12 | 95.3/4.7 |
AFP (ng/L) | ||
≤ 20 vs. > 20 | 210/49 | 81.1/18.9 |
CEA (μg/L) | ||
≤ 10 vs. > 10 | 239/20 | 92.3/7.7 |
CA19-9 (U/L) | ||
≤ 37 vs. > 37 | 124/135 | 47.9/52.1 |
Tumor size (cm) | ||
≤ 5 vs. > 5 | 121/138 | 46.7/53.3 |
Tumor number | ||
Single vs. multiple | 219/40 | 84.6/15.4 |
Satellite | ||
No vs. yes | 159/100 | 61.4/38.6 |
Capsule integrity | ||
Yes vs. no | 14/245 | 5.4/94.6 |
Macrovascular invasion | ||
Yes vs. no | 18/241 | 7.0/93 |
Microvascular invasion | ||
Yes vs. no | 12/247 | 4.7/95.3 |
E-S grade | ||
I vs. II vs. III | 4/222/33 | 1.6/85.7/12.7 |
LNM | ||
Yes vs. no | 40/219 | 15.5/84.5 |
TNM stage | ||
I or II vs. III | 226/33 | 87.3/12.7 |